Clinical trial
Serial Plasma EBV DNA for Patients With Nasopharyngeal Carcinoma
NCT02476669 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Serial Plasma EBV DNA for Patients With Nasopharyngeal Carcinoma
- Lead sponsor
- The University of Hong Kong
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 30, 2010
- Completion date
- December 31, 2021
- Enrollment
- 900 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.